InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,978.00
(
-1.19%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.22
(
-0.06%
)
Bitcoin
61,254.80
(
1.65%
)
Post# of 252337
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119911
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: spartex post# 25620

Tuesday, 03/14/2006 9:28:11 AM

Tuesday, March 14, 2006 9:28:11 AM

Post# of 252337
>Dew, any thoughts on what DNDN is doing as a strategy with their P-11 trial as it relates to FDA BLA filing and review for approval? See this post by eagleeye (yahoo dndn MB); some interesting thoughts on what could possibly play out:
“IMO, DNDN is purposefully waiting so that it can go for the whole enchilada early next year.” <

That post by eagleeye is BS. P-11 is a non-registrational study.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up